Present treatment and future expectations in advanced pancreatic cancer.

Abstract:

:Advanced or metastatic pancreatic cancer is an incurable disease. The main treatment is chemotherapy with cytotoxic agents. On the basis of our experience in clinical trials, the objectives have been to determine response rate, life prolongation and clinical benefit. In our trials and in those of other authors, all of these objectives have been met. Responses remain low; 5-25% of patients have a partial response, life prolongation is significantly achieved versus best supportive care, and clinical benefit is observed in 40-60% of patients. Rarely do patients survive for over 2 years and no patient is cured. The standard cytotoxic treatment is the agent gemcitabine. The addition of other agents, such as cisplatin, irinotecan, oxaliplatin and taxanes, in combination with gemcitabine, has shown higher response rates but overall survival has not significantly increased. Research related to monoclonal or gene therapies for pancreatic cancer has created hope. The horizon has been broadened by a recent report on a tyrosine kinase inhibitor, erlotinib (EGFR inhibitor) which has shown significantly longer median survival, when combined with gemcitabine versus gemcitabine alone. Other anti-angiogenic agents, such as cetuximab and the anti-Her-2, herceptin, are now being tested in ongoing trials. Farnesyl transferase inhibitors represent another direction which research is taking; this is related to the Ras-oncogenes (K-, H- and N-ras) which are known to be involved in signal transduction pathways regulating cell growth and differentiation in many human cancers including pancreatic. Trials of these and other targeting therapies have not produced the expected effectiveness. The combination of monoclonal and/or gene therapies with cytotoxic agents suggests there is hope for the future.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Stathopoulos GP,Androulakis N,Souglakos J,Stathopoulos J,Georgoulias V

subject

Has Abstract

pub_date

2008-03-01 00:00:00

pages

1303-8

issue

2B

eissn

0250-7005

issn

1791-7530

journal_volume

28

pub_type

杂志文章,评审
  • The role of growth factors in central nervous system tumours.

    abstract::The role of growth factors in tumour growth and progression has increasingly been studied over the last few years. This review summarizes the available data and discusses their limitations as well as their potential influence on future therapeutic strategies. A large body of data suggests an important role of EGF, TGF...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Nieder C,Schlegel J,Andratschke N,Thamm R,Grosu AL,Molls M

    更新日期:2003-03-01 00:00:00

  • Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

    abstract:BACKGROUND:Combination chemotherapy of irinotecan and amrubicin for advanced non-small cell lung cancer (NSCLC) has not been fully evaluated. To determine the maximum-tolerated dose (MTD), a phase I study in patients with advanced NSCLC was conducted. MATERIALS AND METHODS:Patients with stage IIIB/IV NSCLC were enroll...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hotta K,Takigawa N,Kiura K,Tabata M,Umemura S,Ogino A,Uchida A,Bessho A,Segawa Y,Shinkai T,Nogami N,Harita S,Okimoto N,Ueoka H,Tanimoto M

    更新日期:2005-05-01 00:00:00

  • Diagnostic value of urinary molecular markers in bladder cancer.

    abstract:OBJECTIVES:In an attempt to find a more sensitive and specific non-invasive diagnostic assay for the detection of bladder cancer cells, the authors assayed the exfoliated cells from patient's voided urine and bladder washing fluids for the presence of telomerase, an enzyme that maintains a cell's chromosomal length, me...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Eissa S,Swellam M,el-Mosallamy H,Mourad MS,Hamdy N,Kamel K,Zaglol AS,Khafagy MM,el-Ahmady O

    更新日期:2003-09-01 00:00:00

  • Elevated reversible and irreversible lipid peroxidation in human oesophageal cancer.

    abstract:BACKGROUND:Cancer of the oesophagus is the most common gastrointestinal malignancy in South African blacks. The aim of this study was to determine the reversible and irreversible lipid peroxidation in cancer of the oesophagus; a feature that has not been assessed before in this or other cancer tissue. METHODS:Biopsies...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Levy RD,Oosthuizen MM,Degiannis E,Lambrechts H

    更新日期:1998-03-01 00:00:00

  • Glycerophosphoinositols as potential markers of ras-induced transformation and novel second messengers.

    abstract::Glycerophosphoinositols are metabolites formed by the sequential action of a phospholipase A2 specific for membrane phosphoinositides, and a lysolipase. Increased levels of these compounds characterize cell lines of different origin transformed by ras and other oncogenes. Thus, glycerophosphoinositols have been propos...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Corda D,Falasca M

    更新日期:1996-05-01 00:00:00

  • Parent of Origin and Prognosis in Familial Breast Cancer in Sweden.

    abstract:BACKGROUND:It has been suggested that prognosis in familial breast cancer could be influenced by the parent of origin, with a worse prognosis when inherited paternally. This study aimed to investigate the effect of the parent of origin on prognosis. PATIENTS AND METHODS:Index patients were divided into two study group...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11442

    authors: Wendt C,Lindblom A,Arver B,VON Wachenfeldt A,Margolin S

    更新日期:2017-03-01 00:00:00

  • Exercise, cancer and the immune response of monocytes.

    abstract::We examined the influence of a regularly moderate endurance training program on qualitative and quantitative alterations of monocytes from 24 breast cancer patients. At the beginning, after 5 weeks and 7 months of bicycle training we analyzed the composition of leucocytes and phagocytotic activity of monocytes using t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Peters C,Lötzerich H,Niemeir B,Schüle K,Uhlenbruck G

    更新日期:1995-01-01 00:00:00

  • P53 expression in patients with malignant and benign breast diseases.

    abstract::Immunohistochemical expression of p53 protein was studied in FNA specimens of 20 breast ductal carcinomas, 20 fibroadenomas and 20 atypical ductal hyperplasia of the breast. Nine cases of breast carcinomas (45%), five fibroadenomas (25%) and four atypical ductal hyperplasia (20%) were found to be p53-immuno-positive. ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kalogeraki A,Panayiotides J,Tamiolakis D,Tzardi M,Chaniotis V,Chalkiadakis G,Melissas J,Stiftsis D,Kanavaros P,Delides GS

    更新日期:2000-05-01 00:00:00

  • C677T gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) in meningiomas and high-grade gliomas.

    abstract:BACKGROUND:Methylenetetrahydrofolate reductase (MTHFR) plays a role in DNA biosynthesis, methylation and repair in actively dividing cells by acting on folate metabolism. A common C677T polymorphism in the gene for MTHFR leads to an enzyme with decreased activity. MTHFR polymorphisms have been studied in various cancer...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kafadar AM,Yilmaz H,Kafadar D,Ergen A,Zeybek U,Bozkurt N,Kuday C,Isbir T

    更新日期:2006-05-01 00:00:00

  • Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia.

    abstract:BACKGROUND:To determine whether an imbalanced interaction between proapototic and antiapoptotic signals may account for the loss of the normal cell growth control in benign prostatic hyperplasia (BPH), the expression of some apoptosis-regulating genes (bcl-2, bax, c-myc, fas) was investigated. PATIENTS AND METHODS:BPH...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Angelucci C,Iacopino F,Lama G,Zelano G,Gianesini G,Sica G,Bono AV

    更新日期:2005-11-01 00:00:00

  • The identification, isolation and characterization of a 67 kilodalton, PNA-reactive autoantigen commonly expressed in human adenocarcinomas.

    abstract::In an attempt to characterize a Peanut Agglutinin (PNA) autoantigen widely expressed in common human adenocarcinomas, monoclonal antibodies (MAbs) were made against PNA-affinity purified glycoproteins from pooled breast cancer membrane biopsy materials. Two IgM MAbs, 167H.1 and 167H.4, were found to react strongly wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Laderoute M,Willans D,Wegmann T,Longenecker M

    更新日期:1994-05-01 00:00:00

  • Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma.

    abstract:BACKGROUND/AIM:Competing mortality risks complicate treatment of elderly melanoma patients potentially leading to conservative management, including no sentinel lymph node biopsy. As systemic immunotherapy offers justification for nodal evaluation, we examined treatment trends among elderly melanoma patients. PATIENTS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14266

    authors: Bateni SB,Johns AJ,Gingrich AA,Gholami S,Bold RJ,Canter RJ,Kirane AR

    更新日期:2020-05-01 00:00:00

  • No circulating cytomegalovirus in five patients with glioblastoma multiforme.

    abstract:BACKGROUND:Glioblastoma multiforme is the most common and most aggressive type of primary brain tumor, accounting for 52% of all primary brain tumor cases and 20% of all intracranial tumors. Recently, evidence for a viral cause has been postulated, possibly SV40 or more likely cytomegalovirus (CMV). One report indicate...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lehrer S,Labombardi V,Green S,Pessin-Minsley MS,Germano IM,Rosenzweig KE

    更新日期:2011-03-01 00:00:00

  • Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.

    abstract:BACKGROUND/AIM:In a previous study, we showed that amentoflavone promotes sorafenib-induced apoptosis in hepatocellular carcinoma (HCC) cells in vitro. However, whether amentoflavone augments anticancer efficacy of sorafenib in HCC in vivo is unknown. The aim of the present study was to verify the anticancer effect of ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12452

    authors: Tsai JJ,Hsu FT,Pan PJ,Chen CW,Kuo YC

    更新日期:2018-04-01 00:00:00

  • Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma.

    abstract:BACKGROUND:Molecular mechanisms responsible for carcinogenesis in upper urinary tract urothelial carcinoma (UUTUC) are not yet clear. This study aimed to examine and correlate the subcellular localization of activin A, maspin, and the androgen receptor (AR) with demographic characteristics, pathological grade, and stag...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rau KM,Chen YJ,Sun MT,Kang HY

    更新日期:2011-05-01 00:00:00

  • A Novel 1,2-Dihydroquinoline Anticancer Agent and Its Delivery to Tumor Cells Using Cationic Liposomes.

    abstract:AIM:We screened nine 1,2-dihydro-quinolines using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HepG2 and SMMC cells and identified ethyl-2-cyano-2-(2- (methoxycarbonyl)allyl)quinoline-1(2H)-carboxylate (compound 5) as a potential anticancer agent. In order to further deve...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ma X,Wu YI,Yang X,Yang S,Li Y,Huang Y,Lee RJ,Bai T,Luo Y

    更新日期:2016-05-01 00:00:00

  • GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis.

    abstract:BACKGROUND:Understanding molecular abnormalities could potentially lead to novel investigational approaches in the molecular epidemiology of lung cancer. These might include the identification of patients at high risk for primary NSCLC and the surveillance of patients with known NSCLC who are being treated using lung-s...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Curigliano G,Ferretti G,Mandalà M,De Pas T,Calabrò MG,Solli P,Noberasc C,de Braud F

    更新日期:2001-09-01 00:00:00

  • Inhibition of angiogenesis and tumorigenesis, and induction of dormancy by p53 in a p53-null thyroid carcinoma cell line in vivo.

    abstract::Our recent in vitro findings for suppression of thrombospondin-1 (TSP1; an antiangiogenic factor) expression by wild-type (wt) p53 in a p53-null thyroid carcinoma cell line, FRO, prompted us to investigate the in vivo effect of exogenous wt-p53 and TSP1 expression on tumor growth and angiogenesis of FRO xenografts in ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nagayama Y,Shigematsu K,Namba H,Zeki K,Yamashita S,Niwa M

    更新日期:2000-07-01 00:00:00

  • Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.

    abstract:UNLABELLED:Lesions containing somatostatin receptors (SSR) in rats and in man can be visualized in vivo using radiolabeled octreotide (OCT) analogs. SSR scintigraphy was initially performed with [123I-Tyr3]OCT and later with [111In-DTRA0]OCT. With the latter the residence time of radioactivity (111In) in SSR-positive t...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Breeman WA,de Jong M,Bernard B,Hofland LJ,Srinivasan A,van der Pluijm M,Bakker WH,Visser TJ,Krenning EP

    更新日期:1998-01-01 00:00:00

  • Urinary gonadotropin peptide in patients with cancer of digestive organs.

    abstract::Urinary gonadotropin peptide (UGP) has been measured in gynecological and urological cancers, but its usefulness in the diagnosis of cancers of digestive organs has not been investigated. In this report, UGP was measured by sandwich enzyme immunoassay in 311 patients, including 166 patients with cancers of digestive o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Motoo Y,Watanabe H,Yamaguchi Y,Mouri I,Fujii T,Yamakawa O,Satomura Y,Okai T,Sawabu N

    更新日期:1996-07-01 00:00:00

  • Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.

    abstract:BACKGROUND:Polymorphisms altering DNA repair capacity may lead to synergistic effects with tobacco carcinogen-induced lung cancer risk. Based on this hypothesis, the relationship between APE1 polymorphism, smoking and the risk of lung cancer was explored. MATERIALS AND METHODS:The distribution of the APE1 Asp148Glu po...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Agaçhan B,Küçükhüseyin O,Aksoy P,Turna A,Yaylim I,Görmüs U,Ergen A,Zeybek U,Dalan B,Isbir T

    更新日期:2009-06-01 00:00:00

  • The protective effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, against HSV-1 infection in mitomycin C-treated mice.

    abstract:BACKGROUND:Immmunosuppression and infectious disease in cancer patients receiving chemotherapy is a serious problem. Immunopotentiating drugs may show a therapeutic efficacy. MATERIALS AND METHODS:The protective effect of Hochu-ekki-to (TJ-41), a Japanese traditional herbal medicine, on mitomycin C (MMC)-induced immun...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kido T,Mori K,Daikuhara H,Tsuchiya H,Ishige A,Sasaki H

    更新日期:2000-11-01 00:00:00

  • Phase II study of topotecan with cisplatin in Japanese patients with small cell lung cancer.

    abstract:BACKGROUND:We conducted a phase II study of topotecan (Tp) with cisplatin (CDDP) in previously untreated Japanese patients with extensive-disease small cell lung cancer (ED-SCLC). PATIENTS AND METHODS:In stage 1, a total of 30 patients were allocated to Tp 0.65 mg/m(2) with CDDP 60 mg/m(2) day 1 or Tp 1.00 mg/m(2) wit...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hosomi Y,Shibuya M,Niho S,Ichinose Y,Kiura K,Sakai H,Takeda K,Kudo S,Eguchi K,Matsui K,Masuda N,Ando M,Watanabe K

    更新日期:2011-10-01 00:00:00

  • Bevacizumab as front-line treatment of brain metastases from solid tumors: a case series.

    abstract:BACKGROUND:Despite the large use of bevabizumab in the treatment of primary tumors of the brain, there is only limited experience with brain metastases (BM) and no experience in the treatment of previously untreated secondary brain lesions. PATIENTS AND METHODS:We treated patients with BM, not suitable for local treat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Zustovich F,Ferro A,Lombardi G,Zagonel V,Fiduccia P,Farina P

    更新日期:2013-09-01 00:00:00

  • Correlation of in vitro cytotoxicity with preclinical in vivo antitumor activity.

    abstract::Several human and murine tumor cell lines were evaluated in an in vitro cytotoxicity assay as prescreens for fermentation extracts and pure materials subsequently tested in vivo against P388 leukemia or B16 melanoma. Each material, regardless of its in vitro cytotoxicity, was evaluated in vivo. At the criteria levels ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rose WC,Schurig JE,Meeker JB

    更新日期:1988-05-01 00:00:00

  • Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.

    abstract::A new transitional cell carcinoma cell line, BCCA-1, derived from a primary urinary bladder carcinoma, was characterized with respect to the growth patterns of in vitro culture, xenotransplantability in SCID mice and immunophenotypic profile. The most unusual finding was a strong tendency of forming many aggregates (m...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chuang CK,Liao SK

    更新日期:2000-03-01 00:00:00

  • Comparison of glucose-consumption and thymidine-incorporation endpoints in histocultured human superficial bladder tumors.

    abstract::Glucose consumption and tritiated thymidine incorporation were monitored for 54 days in histocultured human superficial transitional cell carcinoma of the bladder, indicating that long-term histoculture of human transitional cell carcinoma of the bladder is feasible. The glucose-consumption rate was relatively similar...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chang SG,Lee JH,Hong DH,Lee HL,Chai SE,Hoffman RM

    更新日期:1994-01-01 00:00:00

  • DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance.

    abstract::The production of DNA interstrand crosslinks (ISC) by BCNU and other bifunctional alkylators and the effects of these drugs on the repair of radiation-induced DNA-single strand breaks (SSB) were studied in two human glioblastoma used to assess both DNA-ISCs and DNA-SSBs. BCNU-treated UWR2 and UWR3 cells showed a signi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ali-Osman F,Srivenugopal K,Berger MS,Stein DE

    更新日期:1990-05-01 00:00:00

  • Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.

    abstract::Chloroethyl-nitrosourea is a potent chemotherapeutic agent for brain tumors. However, acquired resistance to this drug has become a serious problem for the treatment of patients. Previously, we established an animal model resistant to nitrosourea (Anticancer Res 19: 5313-5318, 1999). In this study, we evaluate the eff...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Manome Y,Yoshinaga H,Watanabe M,Ohno T

    更新日期:2002-07-01 00:00:00

  • Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways.

    abstract:BACKGROUND:Human choriocarcinoma is the most aggressive type of gestational trophoblastic neoplasia. The expression of epidermal growth factor receptor (EGFR) in choriocarcinomas is significantly higher than those of trophoblastic cells in healthy placentas. Lapatinib is a potent EGFR and human epidermal growth factor ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13355

    authors: Pires LV,Yi Y,Cheng JC,Pizzolato LS,Cordero E,Leung PCK,Brum IS

    更新日期:2019-05-01 00:00:00